Skip to main content

Evidence-Based Supplement Research

Evidence-Based Supplement Research

Magnesium and Improved Blood Lipid Profile

Doses used in studies

mg/day: 150 (median 150, IQR 150–150) — 1 study

Time to effect

Median: 3.7 months · IQR 3.7 months–3.7 months · Range 3.7 months–3.7 months — Reported in 1 of 2 studies

2 of 2 papers

Effect of Magnesium Supplements on Improving Glucose Control, Blood Pressure and Lipid Profile in Patients With Type 2 Diabetes Mellitus: A systematic review and meta-analysis.
- 2025-05-16
- Meta-Analysis · n = 345
- Sultan Qaboos University medical journal 25(1)
- - Nasiba Al Maqrashi
  - Salim Al Busaidi
  - Sara Al-Rasbi
  - Abdullah M Al Alawi
  - Juhaina S Al-Maqbali
- PubMed: 40641714
- DOI: 10.18295/2075-0528.2848
3 Insights on
- Improved Blood Lipid Profile
- High evidence
- Clinical
Additionally, Mg supplementation was linked to lower diastolic blood pressure and potential improvements in lipid profile.
Effect
Beneficial
Effect size
Small
Hepatoprotective effect of combination of L-carnitine and magnesium-hydroxide in nonalcoholic fatty liver disease patients: a double-blinded randomized controlled pilot study.
- 2022-10-01
- RCT
- European review for medical and pharmacological sciences 26(20)
- - R Hazzan
  - N Abu Ahmad
  - W Slim
  - E Mazen
  - Z Neeman
- PubMed: 36314323
- DOI: 10.26355/eurrev_202210_30023
6 Insights on
- Improved Blood Lipid Profile
- High evidence
- Clinical
serum CRP levels, insulin levels, lipid profile and LS were not affected by treatment.
Effect
Neutral
Effect size
Small
Significant
No
Dose
150 mg/day